Insider Trading & Executive Data
Start Free Trial
100 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
Trust Stamp (IDAI) is a privacy-first identity authentication company that builds AI-powered biometrics, irreversible tokenization (IT2) and an Orchestration Layer SaaS platform for KYC/AML, passwordless login, account recovery, fraud reduction and humanitarian identity programs. It sells a mix of licensed technology (hosted and on-premise), services contracts and channel/joint-venture distribution with large partners (notably Mastercard and FIS) and has key customers including an S&P 500 bank and national/humanitarian deployments. Operations are R&D-driven and globally distributed (Malta, Rwanda, UK, Tokyo and smaller engineering teams), with an active IP portfolio (23 issued patents) and SOC2/D‑Seal certifications. Material near-term risks are customer concentration, production rollout delays, regulatory compliance across biometric/privacy regimes, and acute liquidity/going-concern pressure after 2024 losses and recent financings.
With the company explicitly pivoting from one‑time license advances toward recurring SaaS revenue, management incentive plans are likely to emphasize recurring revenue metrics (MRR/ARR growth), customer onboarding-to-production conversion, churn/retention and partner‑milestone attainment (FIS/Mastercard/S&P bank, QID). R&D- and IP-heavy operations suggest continued reliance on equity-based pay (stock options/RSUs) to retain engineers and product leaders, while shorter-term cash constraints have pushed reductions in cash compensation and visible declines in stock‑based compensation in 2025. The company’s frequent financings, warrants and prepaid-warrant accounting items also create dilution risk that teams may factor into long‑term incentive design (performance vesting tied to capital-efficient milestones and certification/go‑live events). Given regulatory sensitivity in biometrics, some compensation may be linked to compliance/certification targets (SOC2, data-handling milestones) to mitigate legal/regulatory risk.
Acute liquidity strain (cash $292k at 6/30/25), recent registered/direct offerings, an ATM facility and secured notes make dilutive financings a recurring theme — insiders may sell or be issued shares/warrants around capital raises, so monitor Form 4 filings for clustered sales or exercises tied to financings. Material, market-moving events for insiders include partner contract awards, production go‑lives (S&P 500 bank, FIS onboardings, QID milestones) and regulatory developments (GDPR/BIPA/APPI/Biometric law changes); these create blackout windows and a higher likelihood of pre- or post-announcement trading activity. Expect disclosures of warrant exercises and related-party transactions (outsourced/insourced development partners) to affect reported ownership; 10b5‑1 plans, exercise activity and timing around ATM sales are key signals for traders and researchers to watch.